Hydrogenics: Pricing and Upsizing of Public Offering of Common Shares
Die untenstehende Meldung ist eine Original-Meldung des Unternehmens. Sie ist nicht von der ECOreporter.de-Redaktion bearbeitet. Die presserechtliche Verantwortlichkeit liegt bei dem meldenden Unternehmen.
MISSISSAUGA, Ontario - Hydrogenics Corporation announced the pricing of its previously announced underwritten public offering of 2,129,031 common shares (the "Offering") at a price of $7.75 per share. Net proceeds to the Company from the Offering are expected to be approximately $15,276,000, after deducting underwriting commissions and other expenses related to the Offering and assuming no exercise of the underwriters' overallotment option. Based upon pricing and investor demand, the Company elected to increase the size of the Offering from the previously announced $15 million to $16.5 million. The Company has also granted to the underwriters a 30-day option to purchase up to an additional 319,354 common shares to cover overallotments in connection with the Offering.
Craig-Hallum Capital Group LLC is acting as sole book-running manager for the Offering. Roth Capital Partners is acting as co-manager for the Offering.
The Offering is expected to close on or about December 16, 2015, subject to customary closing conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approvals of the Toronto Stock Exchange and the NASDAQ Global Market.
The Company intends to use its net proceeds from the Offering primarily for general corporate purposes, including to support any negative cash flows from operating activities.
The Offering is being conducted pursuant to the Company's effective shelf registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission (the "SEC"). The offering will be made only by means of a preliminary prospectus supplement, a final prospectus supplement and the accompanying short form base shelf prospectus. Copies of the preliminary prospectus supplement, and when available, the final prospectus supplement and the accompanying short form base shelf prospectus may be obtained from Craig-Hallum Capital Group, 222 South Ninth Street, Suite 350, Minneapolis, MN 55402, telephone 612-334-6300, email: firstname.lastname@example.org. Electronic copies of the preliminary prospectus supplement, the final prospectus supplement and the accompanying short form base shelf prospectus will also be available free of charge on the SEC's website at www.sec.gov.
The common shares in the Offering will not be qualified for sale under the securities laws of Canada or any province or territory of Canada and are not being offered for sale in Canada or to any resident of Canada. The Company is relying on the exemption set forth in Section 602.1 of the Company Manual of the TSX which exemption provides that the TSX will not apply certain of its standards to eligible interlisted issuers.
Hydrogenics Corporation (www.hydrogenics.com) is a globally recognized developer and provider of hydrogen generation and fuel cell products and services, serving the growing industrial and clean energy markets of today and tomorrow. Based in Mississauga, Ontario, Canada, Hydrogenics has operations in North America and Europe.